OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

MERCK CO. DL-,01/  US58933Y1055  /

TradeGate
1/23/2025  9:52:40 PM Chg. +0.600 Volume Bid10:00:01 PM Ask10:00:01 PM Market Capitalization Dividend Y. P/E Ratio
92.700EUR +0.65% 5,959
Turnover: 550,023.100		 92.500Bid Size: 151 93.000Ask Size: 150 236.17 bill.EUR - -
TeleTrader 10/31/2024 Merck's Q3 sales up 4% to $16.7 billion
GlobeNewswire 7/31/2024 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
TeleTrader 7/30/2024 Merck falls 7% after Q2 earnings report
TeleTrader 7/30/2024 Merck's Q2 sales up 7% to $16.1 billion
GlobeNewswire 7/17/2024 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...
GlobeNewswire 7/9/2024 Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination ...
GlobeNewswire 6/27/2024 Verizon elects Caroline A. Litchfield to its Board of Directors
GlobeNewswire 6/27/2024 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
GlobeNewswire 6/25/2024 Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of...
GlobeNewswire 6/18/2024 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 6/6/2024 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 6/5/2024 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 6/3/2024 Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
TeleTrader 5/29/2024 Merck to buy biotech firm EyeBio for up to $3B
GlobeNewswire 5/29/2024 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire 5/29/2024 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
GlobeNewswire 5/7/2024 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 5/6/2024 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 5/2/2024 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 4/25/2024 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 4/2/2024 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/6/2024 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 3/4/2024 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 2/2/2024 Merck Group to expand investment in South Korea
TeleTrader 2/1/2024 Merck's Q4 sales up 6% to $14.6B